Literature DB >> 17786469

Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992-1999).

Maritza Martel1, Patricia Barron-Rodriguez, Idris Tolgay Ocal, Jorge Dotto, Fattaneh A Tavassoli.   

Abstract

Uniform management of flat DIN 1 (flat epithelial atypia) on core needle biopsy (CNB) concerning surgical excision or clinical follow-up are lacking. In a retrospective review of 1,751 CNB over an 8-year period, we found 63 cases with flat DIN 1 as the most advanced lesion; follow-up was available in 55 cases. Of the 63 patients, 24 had a subsequent biopsy for 15 days to 10 years after the initial CNB, an infiltrating carcinoma was found in nine (14.3%) patients, seven (11.1%) in the ipsilateral, and two (3.2%) in the contralateral breast. Five underwent an excisional biopsy of the ipsilateral breast within less than 3 months of the initial CNB; none had either an invasive or intraepithelial carcinoma. Based on our findings, we consider flat DIN 1 a marker of slightly increased risk for subsequent development of invasive breast carcinoma. When flat DIN 1 is found on CNB as the most advanced lesion after mammographic correlation, an excisional biopsy is not mandatory; however, close follow-up is advised with repeat mammograms for early detection of any clinically occult carcinoma in the vicinity of flat DIN 1 that may have been missed by the CNB.

Entities:  

Mesh:

Year:  2007        PMID: 17786469     DOI: 10.1007/s00428-007-0499-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  32 in total

1.  Columnar cell lesions: current classification and controversies.

Authors:  Selim M Nasser
Journal:  Semin Diagn Pathol       Date:  2004-02       Impact factor: 3.464

2.  Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification.

Authors:  Fattaneh A Tavassoli
Journal:  Nat Clin Pract Oncol       Date:  2005-03

3.  Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?

Authors:  P H Tan; B C-S Ho; S Selvarajan; W M Yap; A Hanby
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

4.  Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

Authors:  N Bijker; J L Peterse; L Duchateau; J P Julien; I S Fentiman; C Duval; S Di Palma; J Simony-Lafontaine; I de Mascarel; M J van de Vijver
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

5.  Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision.

Authors:  M L Darling; D N Smith; S C Lester; C Kaelin; D L Selland; C M Denison; P J DiPiro; D I Rose; E Rhei; J E Meyer
Journal:  AJR Am J Roentgenol       Date:  2000-11       Impact factor: 3.959

6.  Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations.

Authors:  F Moinfar; Y G Man; R A Lininger; C Bodian; F A Tavassoli
Journal:  Am J Surg Pathol       Date:  1999-09       Impact factor: 6.394

7.  Histologic and radiographic analysis of ductal carcinoma in situ diagnosed using stereotactic incisional core breast biopsy.

Authors:  Michelle Bonnett; Tracy Wallis; Michelle Rossmann; Nat L Pernick; Kathryn A Carolin; Mark Segel; David Bouwman; Daniel Visscher
Journal:  Mod Pathol       Date:  2002-02       Impact factor: 7.842

8.  Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34betaE12 antibody.

Authors:  Magali Lacroix-Triki; Eliane Mery; Jean-Jacques Voigt; Luc Istier; Philippe Rochaix
Journal:  Virchows Arch       Date:  2003-04-24       Impact factor: 4.064

9.  Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications.

Authors:  J L Fraser; S Raza; K Chorny; J L Connolly; S J Schnitt
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  16 in total

1.  Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

Authors:  Hans-Peter Sinn; Zeinab Elsawaf; Birgit Helmchen; Sebastian Aulmann
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

2.  Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study.

Authors:  Fouad I Boulos; William D Dupont; Jean F Simpson; Peggy A Schuyler; Melinda E Sanders; Marcia E Freudenthal; David L Page
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

Review 3.  Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?

Authors:  Gulisa Turashvili; Malcolm Hayes; Blake Gilks; Peter Watson; Samuel Aparicio
Journal:  Virchows Arch       Date:  2008-04-24       Impact factor: 4.064

4.  Upgrade Rate of Pure Flat Epithelial Atypia Diagnosed at Core Needle Biopsy: A Systematic Review and Meta-Analysis.

Authors:  Rifat A Wahab; Su-Ju Lee; Margaret E Mulligan; Bin Zhang; Mary C Mahoney
Journal:  Radiol Imaging Cancer       Date:  2021-01-22

5.  Flat epithelial atypia and risk of breast cancer: A Mayo cohort study.

Authors:  Samar M Said; Daniel W Visscher; Aziza Nassar; Ryan D Frank; Robert A Vierkant; Marlene H Frost; Karthik Ghosh; Derek C Radisky; Lynn C Hartmann; Amy C Degnim
Journal:  Cancer       Date:  2015-01-13       Impact factor: 6.860

6.  Morphological parameters of flat epithelial atypia (FEA) in stereotactic vacuum-assisted needle core biopsies do not predict the presence of malignancy on subsequent surgical excision.

Authors:  Simonetta Bianchi; Benedetta Bendinelli; Isabella Castellano; Quirino Piubello; Giuseppe Renne; Maria Grazia Cattani; Domenica Di Stefano; Giovanna Carrillo; Licia Laurino; Alessandra Bersiga; Carmela Giardina; Stefania Dante; Carla Di Loreto; Carmela Quero; Concetta Maria Antonacci; Domenico Palli
Journal:  Virchows Arch       Date:  2012-09-01       Impact factor: 4.064

Review 7.  Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.

Authors:  Kelly L Mooney; Lawrence W Bassett; Sophia K Apple
Journal:  Mod Pathol       Date:  2016-08-19       Impact factor: 7.842

8.  Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.

Authors:  Sarah A Aroner; Laura C Collins; Stuart J Schnitt; James L Connolly; Graham A Colditz; Rulla M Tamimi
Journal:  Breast Cancer Res       Date:  2010-08-06       Impact factor: 6.466

9.  Flat epithelial atypia with and without atypical ductal hyperplasia: to re-excise or not. Results of a 5-year prospective study.

Authors:  Ikechukwu Uzoaru; Bradley R Morgan; Zheng G Liu; Frank J Bellafiore; Farah S Gaudier; Jeanne V Lo; Kourosh Pakzad
Journal:  Virchows Arch       Date:  2012-09-08       Impact factor: 4.064

10.  Flat epithelial atypia: conservative management of patients without residual microcalcifications post-vacuum-assisted breast biopsy.

Authors:  Simone Schiaffino; Licia Gristina; Alessandro Villa; Simona Tosto; Francesco Monetti; Franca Carli; Massimo Calabrese
Journal:  Br J Radiol       Date:  2017-11-09       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.